Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72611 record(s)

Req # A-2020-000071

Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02606418, E2B_02608012, E2B_02607127, E2B_02613556, E2B_02578626, E2B_02585269, E2B_02642108, E2 B_02643457, E2B_02643564, E2B_02645077, E2B_01361047, E2B_00778650,…

Organization: Health Canada

742 page(s)
July 2020

Req # A-2020-000076

Adverse Reaction Report (AER) for INSULIN GLARGINE. Report numbers: 000725089, 000725777, 000726058, 000726283, E2B_02553743, E2B_02609446, E2B_02631995, 000724670, 725090, E2B_02551031.

Organization: Health Canada

96 page(s)
July 2020

Req # A-2020-000102

Adverse Reaction Report (AER). Report number: E2B_02983084.

Organization: Health Canada

9 page(s)
July 2020

Req # A-2020-000126

Adverse Reaction Report (AER). Report numbers: 000733571, 000733940, E2B_02866902, E2B_02866905.

Organization: Health Canada

47 page(s)
July 2020

Req # A-2020-000130

Adverse Reaction Report (AER). Report numbers: 000719523, 000719683, 000719639, 000719687, E2B_02155932, E2B_02158784, E2B_02162429, E2B_02181848, E2B_02191642, 000719746, E2B_02251476.

Organization: Health Canada

104 page(s)
July 2020

Req # A-2020-000136

Adverse Reaction Report (AER). Report numbers: E2B_02937202, E2B_02937350, E2B_02937259, E2B_02937361.

Organization: Health Canada

132 page(s)
July 2020

Req # A-2020-000150

Adverse Reaction Report (AER). Report numbers: E2B_02972734, E2B_02974799.

Organization: Health Canada

31 page(s)
July 2020

Req # A-2020-000153

Adverse Reaction Report (AER). Report numbers: E2B_02866495, E2B_02866496.

Organization: Health Canada

28 page(s)
July 2020

Req # A-2020-000165

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02919253.

Organization: Health Canada

8 page(s)
July 2020

Req # A-2020-000170

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02972599.

Organization: Health Canada

6 page(s)
July 2020
Date modified: